• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肾癌:96例行肾切除术患者的计算机分析

Renal carcinoma: computer analysis of 96 patients treated by nephrectomy.

作者信息

Boxer R J, Waisman J, Lieber M M, Mampaso F M, Skinner D G

出版信息

J Urol. 1979 Nov;122(5):598-601. doi: 10.1016/s0022-5347(17)56521-0.

DOI:10.1016/s0022-5347(17)56521-0
PMID:501810
Abstract

We submitted to computer analysis 109 items of pathologic, clinical and survival data from 96 patients with renal carcinoma treated by nephrectomy with or without adjuvant therapy between 1956 and 1976. The combined 1, 5 and 10-year calculated survival rates for potentially curable non-metastatic renal carcinoma (stages I, II and III, provided the regional lymph nodes were not involved) were 95, 61 and 47 per cent, respectively, compared to 1, 5 and 10-year survival rates of 61, 5 and 0 per cent, respectively, for stage IV tumors. The cytoplasmic appearance (clear or granular) was not a significant microscopic feature relevant to survival of the patient but the grade of the tumor was predictive of the outcome of disease. Other features of renal carcinoma, particularly invasion of the renal vein and, to a lesser degree, perinephric fat, were not as prognostically significant in this series. In this retrospective study we further analyze the clinical, radiologic, pathologic and survival data of this group of patients.

摘要

我们将1956年至1976年间接受肾切除术(无论有无辅助治疗)的96例肾癌患者的109项病理、临床和生存数据进行了计算机分析。对于潜在可治愈的非转移性肾癌(I、II和III期,前提是区域淋巴结未受累),计算得出的1年、5年和10年联合生存率分别为95%、61%和47%,而IV期肿瘤的1年、5年和10年生存率分别为61%、5%和0%。细胞质外观(透明或颗粒状)并非与患者生存相关的显著微观特征,但肿瘤分级可预测疾病转归。肾癌的其他特征,特别是肾静脉侵犯以及程度较轻的肾周脂肪侵犯,在本系列研究中预后意义不大。在这项回顾性研究中,我们进一步分析了该组患者的临床、放射学、病理和生存数据。

相似文献

1
Renal carcinoma: computer analysis of 96 patients treated by nephrectomy.肾癌:96例行肾切除术患者的计算机分析
J Urol. 1979 Nov;122(5):598-601. doi: 10.1016/s0022-5347(17)56521-0.
2
Results of radical nephrectomy in 178 cases of renal cell adenocarcinoma.
Can J Surg. 1979 Sep;22(5):409-12.
3
Tumor size and Fuhrman grade further enhance the prognostic impact of perinephric fat invasion and renal vein extension in T3a staging of renal cell carcinoma.肿瘤大小和富尔曼分级进一步增强了肾周脂肪浸润和肾静脉受累在肾细胞癌T3a分期中的预后影响。
Int J Urol. 2017 Jan;24(1):51-58. doi: 10.1111/iju.13237. Epub 2016 Oct 18.
4
The influence of pNx/pN0 grouping in a multivariate setting for outcome modeling in patients with clear cell renal cell carcinoma.在多变量环境中,pNx/pN0分组对透明细胞肾细胞癌患者预后建模的影响。
J Urol. 2002 Jul;168(1):56-60.
5
Risk factors for locoregional relapse after radical nephrectomy.根治性肾切除术后局部区域复发的危险因素。
Asia Pac J Clin Oncol. 2018 Jun;14(3):192-197. doi: 10.1111/ajco.12684. Epub 2017 May 10.
6
Impact of Microscopic Wall Invasion of the Renal Vein or Inferior Vena Cava on Cancer-specific Survival in Patients with Renal Cell Carcinoma and Tumor Thrombus: A Multi-institutional Analysis from the International Renal Cell Carcinoma-Venous Thrombus Consortium.国际肾细胞癌-静脉血栓形成联盟多机构分析:肾细胞癌合并肿瘤栓子患者肾静脉或下腔静脉镜下壁侵犯对癌症特异性生存的影响。
Eur Urol Focus. 2018 Apr;4(3):435-441. doi: 10.1016/j.euf.2017.01.009. Epub 2017 Feb 9.
7
Results of radical thoraco-abdominal nephrectomy in the treatment of renal cell carcinoma.
Prog Clin Biol Res. 1982;100:481-8.
8
The role of lymphadenectomy in the management of renal cell carcinoma.淋巴结清扫术在肾细胞癌治疗中的作用。
Urol Clin North Am. 1980 Oct;7(3):705-9.
9
The results of radical nephrectomy for renal cell carcinoma.肾细胞癌根治性肾切除术的结果。
Trans Am Assoc Genitourin Surg. 1968;60:122-9.
10
Renal cell carcinoma: natural history and results of treatment.肾细胞癌:自然病史与治疗结果
J Urol. 1978 Jun;119(6):722-6. doi: 10.1016/s0022-5347(17)57611-9.

引用本文的文献

1
[The WHO/ISUP grading system for renal carcinoma].[世界卫生组织/国际泌尿病理学会肾癌分级系统]
Pathologe. 2016 Jul;37(4):355-60. doi: 10.1007/s00292-016-0171-y.
2
A medical oncologist's approach to immunotherapy for advanced renal tumors: is nephrectomy indicated?
Curr Urol Rep. 2004 Feb;5(1):19-24. doi: 10.1007/s11934-004-0006-x.
3
Comparison of grading systems for estimating the prognosis of renal cell carcinoma.用于评估肾细胞癌预后的分级系统比较。
Int Urol Nephrol. 1998;30(4):391-7. doi: 10.1007/BF02550216.
4
Biology of metastasis and its clinical implications: renal-cell cancer.
World J Urol. 1996;14(3):175-81. doi: 10.1007/BF00186897.
5
Renal cell carcinoma: correlation of CT findings with nuclear morphologic grading in 100 tumors.肾细胞癌:100例肿瘤的CT表现与核形态学分级的相关性
Abdom Imaging. 1994 May-Jun;19(3):262-6. doi: 10.1007/BF00203523.
6
Hypernephroma.肾细胞癌
Br Med J (Clin Res Ed). 1981 Mar 14;282(6267):844-5.
7
Flow-cytophotometric studies in renal carcinoma.肾癌的流式细胞光度术研究
Urol Res. 1983;11(3):121-5. doi: 10.1007/BF00257716.
8
Nuclear grading of renal cell carcinomas--is morphometry necessary?肾细胞癌的核分级——形态测量学是否必要?
J Cancer Res Clin Oncol. 1991;117(1):73-8. doi: 10.1007/BF01613201.